Article Published 18 Sep 2025 Medical Wearables Under The Microscope: U.S. Regulatory, Data Privacy And Cybersecurity Perspectives United States Food, Drugs, Healthcare, Life Sciences AO A&O Shearman
Article Published 18 Sep 2025 Drug And Medical Device Regulation Under The Trump Administration United States Food, Drugs, Healthcare, Life Sciences AO A&O Shearman
Article Published 18 Sep 2025 Antitrust In Life Sciences—key European Developments For Pharma Companies United States Antitrust/Competition Law AO A&O Shearman
Article Published 17 Sep 2025 Historic UPC Court Of Appeal Decision Changes The Landscape For European Generics United States Intellectual Property AO A&O Shearman
Article Published 17 Sep 2025 Recent Federal Developments For September 2025 United States Energy and Natural Resources BC Bergeson & Campbell
Article Published 17 Sep 2025 NIH Prepares To Launch AI Initiative Transforming Medical Imaging Data Analysis And Advancing Personalized Medicine United States Food, Drugs, Healthcare, Life Sciences FL Foley & Lardner
Article Published 17 Sep 2025 Mintz IRA Update — Redesigning Part D For CY 2026 United States Food, Drugs, Healthcare, Life Sciences M Mintz
Article Published 17 Sep 2025 Mintz IRA Update — Under Pressure: The Trump Administration's Drug Pricing Executive Orders United States Food, Drugs, Healthcare, Life Sciences M Mintz
Article Published 17 Sep 2025 Monthly Federal Developments Memorandum United States Energy and Natural Resources BC Bergeson & Campbell
Article Published 17 Sep 2025 PhRMA's 2025 Policy Agenda And The Industry's Crossroads With The IRA And Drug Pricing Reform United States Food, Drugs, Healthcare, Life Sciences M Mintz
Article Published 16 Sep 2025 European Commission's Call For Evidence On The Revision Of The MDR/IVDR United States Food, Drugs, Healthcare, Life Sciences AP Arnold & Porter
Article Published 16 Sep 2025 How Stock Transfer Restrictions In Stockholder Agreements Shape Ownership And Control United States Corporate/Commercial Law C Crowley Law LLC
Article Published 16 Sep 2025 FDA On The Offense! Targeting Pharmaceutical Company Drug Advertising In Wave Of Enforcement Actions United States Food, Drugs, Healthcare, Life Sciences FL Foley & Lardner
Article Published 15 Sep 2025 DOJ And FDA Increase Enforcement On Unauthorized Vape Sales United States Food, Drugs, Healthcare, Life Sciences MB Mayer Brown
Article Published 12 Sep 2025 DTC Reforms And MAHA Proclamations: The MAHA Agenda And Its Focus On Prescription Drugs Continues To Take Shape United States Food, Drugs, Healthcare, Life Sciences AP Arnold & Porter
Article Published 12 Sep 2025 HHS Announces New And Renewed Efforts To Promote Health Information Sharing And Interoperability United States Food, Drugs, Healthcare, Life Sciences RG Ropes & Gray LLP
Article Published 12 Sep 2025 HHS And FDA Attempt To Crackdown On Deceptive DTC Rx Drug Advertising Following Presidential Memo United States Food, Drugs, Healthcare, Life Sciences FH Foley Hoag LLP
Article Published 11 Sep 2025 Transparency So Radical It Overlooks Law And Tradition: FDA Releases Complete Response Letters For Unapproved Drugs United States Food, Drugs, Healthcare, Life Sciences AP Arnold & Porter
Article Published 10 Sep 2025 What If The Biosimilar Wave Is Just A Ripple? United States Food, Drugs, Healthcare, Life Sciences AM Alvarez & Marsal
Article Published 10 Sep 2025 ISO Publishes Standards For Graphene-Related 2D Materials United States Food, Drugs, Healthcare, Life Sciences BC Bergeson & Campbell